Executives On The Move: Science Appointments Made At Amneal Pharma And Hemostemix, And Board Changes At Silence Therapeutics
Executive Summary
Specialty and generics drug company Amneal Pharmaceuticals hires a CSO and stem cell firm Hemostemix adds a president and CMO. Also, RNAi therapeutics business Silence Therapeutics names a new chairman.